FSR launched its Clinical and Research Fellowship Program in Fall 2017. We’ve invested over $1 million into this program, which aims to increase the number of specialized doctors and researchers in the sarcoidosis space. This investment in early career development will ensure that patients have access to more qualified providers in the future.
This Spring, FSR selected a new recipient of the FSR Clinical and Research Fellowship, Liao Shu-Yi.
Upon completion of medical school, I had the opportunity to attend Harvard School of Public Health to pursue my doctoral degree (Doctor of Science) in molecular epidemiology. After my Residency and Pulmonary and Critical Care Medicine Fellowship training at the University of California-Riverside and Davis, I joined National Jewish Health as a junior faculty focused on sarcoidosis patient care and research under Dr. Lisa Maier’s mentorship (co-mentor with Dr. Tasha Fingerlin) in July, 2019. I have begun evaluating sarcoidosis patients with multiorgan involvement in the clinics. In addition to the clinical work, I have worked with the sarcoidosis research group closely.
The title of my research proposal in the FSR fellowship grant is “An omics precision medicine approach to explore the susceptibility and phenotypes of sarcoidosis”. This will represent one of the very few studies that integrate omics data to identify disease pathways and potential pathogenesis and predict the population with chronic progressive sarcoidosis. These findings can guide us to develop and utilize molecular signatures to inform clinical decision-making in sarcoidosis and ultimately can lead to individualized treatment.
With this FSR fellowship grant, my goal is to attain the necessary skills, training, and guidance to become a physician-scientist focusing on sarcoidosis patient management and research and obtain additional training which would ultimately lead to a future K-award application.